Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 31, 2014, Pages

  Céspedes, Pablo F ^a   Bueno, Susan M ^a   Ramírez, Bruno A ^a   Gomez, Roberto S ^a,b   Riquelme, Sebastián A ^a,b   Palavecino, Christian E ^a   Mackern Oberti, Juan Pablo ^a   Mora, Jorge E ^a   Depoil, David ^c,d   Sacristań, Catarina ^c   Cammer, Michael ^c   Creneguy, Alison ^b   Nguyen, Tuan H ^b   Riedel, Claudia A ^a   Dustin, Michael L ^c,d   Kalergis, Alexis M ^a,b,e  

^a Pontificia Universidad Católica de Chile   (Chile)

^b INSERM   (France)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

cSMAC; Nucleocapsid protein; PSMAC; T lymphocyte priming

Indexed keywords

CD2 ANTIGEN; CD69 ANTIGEN; CELL SURFACE PROTEIN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NUCLEOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL DENSITY; CELL MEMBRANE; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; FLOW CYTOMETRY; GOLGI COMPLEX; IMMUNE DYSREGULATION; IMMUNOLOGICAL SYNAPSE; LIPID BILAYER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANS GOLGI NETWORK; VIRION; VIRUS ATTACHMENT; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS REPLICATION;

CSMAC; NUCLEOCAPSID PROTEIN; PSMAC; T LYMPHOCYTE PRIMING;

ANIMALS; BREFELDIN A; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL LINE; CELL MEMBRANE; DENDRITIC CELLS; GOLGI APPARATUS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOLOGICAL SYNAPSES; LIPID BILAYERS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NUCLEOPROTEINS; PEPTIDES; PROTEIN TRANSPORT; RECEPTORS, ANTIGEN, T-CELL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84905647856     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1400760111     Document Type: Article

References (61)

1. Nair H, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 375(9725):1545-1555.
2. Ohuma EO, et al. (2012) The natural history of respiratory syncytial virus in a birth cohort: The influence of age and previous infection on reinfection and disease. Am J Epidemiol 176(9):794-802.
3. Henderson FW, Collier AM, Clyde WA, Jr, Denny FW (1979) Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300(10):530-534. (Pubitemid 9167827)
4. Nokes DJ, et al. (2008) Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis 46(1):50-57. (Pubitemid 351263559)
5. Walsh EE (2011) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 32(4):423-432.
6. DeVincenzo JP, et al. (2010) Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 182(10):1305-1314.
7. Welliver TP, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195(8):1126-1136. (Pubitemid 46543443)
8. McKinstry KK, et al. (2012) Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 122(8):2847-2856.
9. Boonnak K, Subbarao K (2012) Memory CD4+ T cells: Beyond "helper" functions. J Clin Invest 122(8):2768-2770.
10. Rasheed MA, et al. (2013) Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells. J Virol 87(13):7737-7746.
11. Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S (2008) Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity 28(2):258-270. (Pubitemid 351222655)
12. Blair DA, et al. (2011) Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol 187(5):2310-2321.
13. Zammit DJ, Cauley LS, Pham QM, Lefrançois L (2005) Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22(5):561-570. (Pubitemid 40719192)
14. Rothoeft T, et al. (2007) Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol 150(2):263-273. (Pubitemid 47609573)
15. Chang J, Braciale TJ (2002) Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 8(1):54-60. (Pubitemid 34101729)
16. Guerrero-Plata A, et al. (2006) Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34(3):320-329. (Pubitemid 43320713)
17. Le Nouën C, et al. (2009) Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology 385(1):169-182.
18. Le Nouën C, et al. (2010) Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS ONE 5(11):e15017.
19. Munir S, et al. (2011) Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7(4):e1001336.
20. González PA, et al. (2008) Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci USA 105(39):14999-15004.
21. Grakoui A, et al. (1999) The immunological synapse: A molecular machine controlling T cell activation. Science 285(5425):221-227. (Pubitemid 29329988)
22. Tseng SY, Waite JC, Liu M, Vardhana S, Dustin ML (2008) T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase C theta. J Immunol 181(7):4852-4863.
23. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML (2006) T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25(1):117-127. (Pubitemid 44066825)
24. Wiedemann A, et al. (2005) T-cell activation is accompanied by an ubiquitination process occurring at the immunological synapse. Immunol Lett 98(1):57-61. (Pubitemid 40409819)
25. Milstein O, et al. (2008) Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse. J Biol Chem 283(49):34414-34422.
26. Choudhuri K, Wiseman D, Brown MH, Gould K, van der Merwe PA (2005) T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 436(7050):578-582. (Pubitemid 41112933)
27. Ilani T, Khanna C, Zhou M, Veenstra TD, Bretscher A (2007) Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin. J Cell Biol 179(4):733-746. (Pubitemid 350146258)
28. Graf B, Bushnell T, Miller J (2007) LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse. J Immunol 179(3):1616-1624.
29. de Giuli C, Kawai S, Dales S, Hanafusa H (1975) Absence of surface projections of some noninfectious forms of RSV. Virology 66(1):253-260.
30. Hallak LK, Spillmann D, Collins PL, Peeples ME (2000) Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74(22):10508-10513.
31. Corish P, Tyler-Smith C (1999) Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 12(12):1035-1040. (Pubitemid 30011478)
32. Bermingham A, Collins PL (1999) The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci USA 96(20):11259-11264. (Pubitemid 29487368)
33. Brown G, Aitken J, Rixon HW, Sugrue RJ (2002) Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J Gen Virol 83(Pt 3):611-621. (Pubitemid 34183006)
34. Miller SG, Carnell L, Moore HH (1992) Post-Golgi membrane traffic: Brefeldin A inhibits export from distal Golgi compartments to the cell surface but not recycling. J Cell Biol 118(2):267-283.
35. Collins PL, Mottet G (1991) Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 72(Pt 12):3095-3101.
36. Collins PL, Mottet G (1992) Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: Altered O-glycosylation in the presence of brefeldin A. J Gen Virol 73(Pt 4):849-863.
37. Utley TJ, et al. (2008) Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci USA 105(29):10209-10214.
38. Jeffree CE, et al. (2007) Ultrastructural analysis of the interaction between F-actin and respiratory syncytial virus during virus assembly. Virology 369(2):309-323. (Pubitemid 350103594)
39. Doms RW, Russ G, Yewdell JW (1989) Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol 109(1):61-72. (Pubitemid 19180119)
40. Mempel TR, Henrickson SE, Von Andrian UH (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427(6970):154-159. (Pubitemid 38094955)
41. Skokos D, et al. (2007) Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat Immunol 8(8):835-844. (Pubitemid 47099036)
42. Friedman RS, Beemiller P, Sorensen CM, Jacobelli J, Krummel MF (2010) Real-time analysis of T cell receptors in naive cells in vitro and in vivo reveals flexibility in synapse and signaling dynamics. J Exp Med 207(12):2733-2749.
43. van der Merwe PA, et al. (1994) Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33(33):10149-10160.
44. James JR, Vale RD (2012) Biophysical mechanism of T-cell receptor triggering in a reconstituted system. Nature 487(7405):64-69.
45. Fearns R, Peeples ME, Collins PL (1997) Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236(1):188-201. (Pubitemid 27410366)
46. Horikami SM, Curran J, Kolakofsky D, Moyer SA (1992) Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 66(8):4901-4908.
47. Buchholz CJ, Spehner D, Drillien R, Neubert WJ, Homann HE (1993) The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly. J Virol 67(10):5803-5812. (Pubitemid 23277488)
48. Curran J, Marq JB, Kolakofsky D (1995) An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol 69(2):849-855.
49. Castagné N, et al. (2004) Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 85(Pt 6):1643-1653. (Pubitemid 38807762)
50. Oliveira AP, et al. (2013) Human respiratory syncytial virus N, P and M protein interactions in HEK-293T cells. Virus Res 177(1):108-112.
51. Marie JC, et al. (2004) Cell surface delivery of the measles virus nucleoprotein: A viral strategy to induce immunosuppression. J Virol 78(21):11952-11961. (Pubitemid 39390780)
52. Ravanel K, et al. (1997) Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med 186(2):269-278. (Pubitemid 27328027)
53. Bangham CR, et al. (1986) Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol 137(12):3973-3977. (Pubitemid 17215331)
54. Cherrie AH, Anderson K, Wertz GW, Openshaw PJ (1992) Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J Virol 66(4):2102-2110.
55. Venter M, Rock M, Puren AJ, Tiemessen CT, Crowe JE, Jr (2003) Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol 77(13):7319-7329. (Pubitemid 36734500)
56. McDermott DS, Knudson CJ, Varga SM (2014) Determining the breadth of the respiratory syncytial virus-specific T cell response. J Virol 88(6):3135-3143.
57. Lalvani A, et al. (1997) Rapid effector function in CD8+ memory T cells. J Exp Med 186(6):859-865. (Pubitemid 27407347)
58. Gubser PM, et al. (2013) Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol 14(10):1064-1072.
59. Choudhuri K, et al. (2014) Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 507(7490):118-123.
60. Hallak LK, Collins PL, Knudson W, Peeples ME (2000) Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271(2):264-275. (Pubitemid 30461305)
61. Gomez RS, et al. (2014) Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies. J Med Virol 86(7):1256-1266. Tecnológico Tecnológico Tecnológico Científica y Tecnológica